Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

The burgeoning burden of respiratory syncytial virus among children.

Hall CB.

Infect Disord Drug Targets. 2012 Apr;12(2):92-7. Review.

PMID:
22335498
2.

Respiratory syncytial virus infection in adults.

Walsh EE.

Semin Respir Crit Care Med. 2011 Aug;32(4):423-32. doi: 10.1055/s-0031-1283282. Epub 2011 Aug 19. Review.

PMID:
21858747
3.

Management of respiratory syncytial virus with lower respiratory tract infection in infants and children.

Garzon LS, Wiles L.

AACN Clin Issues. 2002 Aug;13(3):421-30. Review.

PMID:
12151995
4.
5.

Respiratory syncytial virus disease: update on treatment and prevention.

Krilov LR.

Expert Rev Anti Infect Ther. 2011 Jan;9(1):27-32. doi: 10.1586/eri.10.140. Review.

PMID:
21171875
6.

Respiratory syncytial virus infections in children.

Staat MA.

Semin Respir Infect. 2002 Mar;17(1):15-20. Review.

PMID:
11891515
7.

[Respiratory syncytial virus].

Tsutsumi H.

Uirusu. 2005 Jun;55(1):77-84. Review. Japanese.

8.

Respiratory syncytial virus infection in adults.

Murata Y, Falsey AR.

Antivir Ther. 2007;12(4 Pt B):659-70. Review.

PMID:
17944273
9.

Respiratory syncytial virus infection in adult populations.

Walsh EE, Falsey AR.

Infect Disord Drug Targets. 2012 Apr;12(2):98-102. Review.

PMID:
22335500
10.

Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment.

Van Woensel JB, Kimpen JL, Brand PL.

Minerva Pediatr. 2001 Apr;53(2):99-106. Review.

PMID:
11404731
11.

Economic impact of viral respiratory disease in children.

Meissner HC.

J Pediatr. 1994 May;124(5 Pt 2):S17-21. Review.

PMID:
8169753
12.

Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.

Wang D, Cummins C, Bayliss S, Sandercock J, Burls A.

Health Technol Assess. 2008 Dec;12(36):iii, ix-x, 1-86. Review.

13.

Respiratory syncytial virus: how, why and what to do.

Rodriguez R, Ramilo O.

J Infect. 2014 Jan;68 Suppl 1:S115-8. doi: 10.1016/j.jinf.2013.09.021. Epub 2013 Oct 27. Review.

PMID:
24171820
14.

Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals.

Murray J, Saxena S, Sharland M.

Arch Dis Child. 2014 May;99(5):469-73. doi: 10.1136/archdischild-2013-303764. Epub 2014 Jan 24. Review.

PMID:
24464977
15.

Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.

Groothuis JR, Hoopes JM, Hemming VG.

Adv Ther. 2011 Feb;28(2):110-25. doi: 10.1007/s12325-010-0101-y. Epub 2011 Feb 4. Review.

PMID:
21318605
16.

Nosocomial respiratory syncytial virus infections in children's wards.

Mlinaric-Galinovic G, Varda-Brkic D.

Diagn Microbiol Infect Dis. 2000 Aug;37(4):237-46. Review.

PMID:
10974574
17.

Therapy for respiratory tract infections caused by respiratory syncytial virus.

van Woensel J, Kimpen J.

Eur J Pediatr. 2000 Jun;159(6):391-8. Review.

PMID:
10867842
18.

Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.

Carbonell-Estrany X, Bont L, Doering G, Gouyon JB, Lanari M.

Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):891-9. doi: 10.1007/s10096-008-0520-8. Epub 2008 Jul 16. Review.

PMID:
18629558
19.

Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.

Wendt CH, Hertz MI.

Semin Respir Infect. 1995 Dec;10(4):224-31. Review.

PMID:
8668850
20.

Respiratory syncytial virus: A continuing culprit and conundrum.

Hall CB.

J Pediatr. 1999 Aug;135(2 Pt 2):2-7. Review.

PMID:
10431132
Items per page

Supplemental Content

Write to the Help Desk